• Co-Diagnostics named Wes Lindsey as chief scientific officer on July 16, 2026.
• Lindsey has more than 20 years in molecular diagnostics, including leading assay development teams through more than a dozen FDA 510(k) submissions.
• He holds a PhD in Genetics and Molecular Biology from Emory University, plus an MBA from Georgia State University.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.